相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Howard C. Masuoka et al.
YEAR IN DIABETES AND OBESITY (2013)
Prescription Pattern of Chinese Herbal Products for Diabetes Mellitus in Taiwan: A Population-Based Study
Chung-Yu Huang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats
Ling Shen et al.
JOURNAL OF LIPID RESEARCH (2013)
Lipotoxicity in the liver
Veronika Zambo et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Entry of Hepatitis B Virus into Immortalized Human Primary Hepatocytes by Clathrin-Dependent Endocytosis
Hsiu-Chen Huang et al.
JOURNAL OF VIROLOGY (2012)
Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
Briohny W. Smith et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats
Ye Xiong et al.
DIABETES (2010)
Histopathology of Non-Alcoholic Fatty Liver Disease
Elizabeth M. Brunt
CLINICS IN LIVER DISEASE (2009)
Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study
Christine Carter-Kent et al.
HEPATOLOGY (2009)
Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria
Seiji Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
Rudolf Zechner et al.
JOURNAL OF LIPID RESEARCH (2009)
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Winston Dunn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Ginsenosides Rb1 and Rg1 Suppress Triglyceride Accumulation in 3T3-L1 Adipocytes and Enhance β-Cell Insulin Secretion and Viability in Min6 Cells via PKA-Dependent Pathways
Sunmin Park et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
Valerio Nobili et al.
HEPATOLOGY (2008)
Impairment of nutritional regulation of adipose triglyceride lipase expression with age
A. Caimari et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis
Brendan N. Reid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang
Ching-Chu Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells
Chih-Li Lin et al.
JOURNAL OF LIPID RESEARCH (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state
Johan W. E. Jocken et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease
Samir Parekh et al.
GASTROENTEROLOGY (2007)
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes
Hussein H. Aly et al.
JOURNAL OF HEPATOLOGY (2007)
AMP-activated protein kinase: role in metabolism and therapeutic implications
Greg Schimmack et al.
DIABETES OBESITY & METABOLISM (2006)
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
Benoit Viollet et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Treatment of non-alcoholic fatty liver disease
LA Adams et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
QM Anstee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization
R Burcelin et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1
SP Cousin et al.
ENDOCRINOLOGY (2001)
The db/db mouse, a model for diabetic dyslipidemia: Molecular characterization and effects of Western diet feeding
K Kobayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
分享论文
